Toxicology Regulatory Services | PDE Safety Assessment & Benefit-Risk Analysis
Specialist toxicology regulatory services for pharmaceutical and medical device companies — delivered by RABT Global’s expert regulatory team.
Toxicology regulatory services are a critical component of pharmaceutical and medical device regulatory submissions — providing the scientific evidence base for safety claims, permissible exposure levels, and benefit-risk assessments required by health authorities worldwide. Without robust, expertly prepared toxicology reports, submissions risk deficiencies, additional data requirements, or outright rejection. At RABT Global, our pharmaceutical toxicology consulting team delivers scientifically rigorous, regulatory-compliant toxicology assessments that meet FDA, EMA, MHRA, and ICH standards.
How RABT Global Delivers This Service
Initial Consultation & Needs Assessment
We review your specific toxicology regulatory services requirements, target markets, and timelines to scope the engagement.
Strategy & Planning
Our specialist team develops a tailored approach aligned with applicable regulatory requirements and your commercial objectives.
Delivery & Execution
We execute the defined scope — producing regulatory-compliant deliverables to the highest quality standards.
Review & Quality Assurance
All deliverables undergo independent review and quality check before client delivery.
Ongoing Support
RABT Global remains available for follow-up queries, regulatory authority interactions, and lifecycle support.
Our Toxicology & Safety Reports (PDE / Benefit-Risk)
Permitted Daily Exposure (PDE) Assessments
ICHQ3C-aligned PDE reports for pharmaceutical cleaning validation and GMP compliance
Threshold of Toxicological Concern (TTC) Analysis
ICH Q3A/B-aligned impurity safety evaluation and TTC assessments
Benefit-Risk Assessment Services
structured benefit-risk analyses for marketing applications and post-approval safety reviews
Nonclinical Safety Regulatory Reports
integrated summaries of non-clinical toxicology data for CTD Module 4 submissions
Impurity Safety Evaluation PDE
elemental impurity risk assessments per ICH Q3D
Safety Assessment Regulatory Services
environmental risk assessment (ERA), carcinogenicity assessment, reproductive toxicology
Toxicology Risk Assessment Services
product-specific toxicological risk assessment for regulatory submission or GMP compliance
Regulatory Toxicology Support
expert scientific opinion and toxicology consultation for health authority queries
What are Toxicology & Safety Reports (PDE / Benefit-Risk)?
Toxicology & Safety Reports (PDE / Benefit-Risk) provide life sciences companies with specialist toxicology regulatory services expertise — supporting regulatory compliance, market access, and product lifecycle management across pharmaceutical and medical device sectors. RABT Global’s toxicology regulatory services are delivered by qualified regulatory professionals with deep expertise in FDA, EMA, MHRA, CDSCO, and global regulatory requirements.
Toxicology & Safety Reports (PDE / Benefit-Risk) — FAQs
A: A Permitted Daily Exposure (PDE) assessment is a toxicological evaluation that establishes the maximum acceptable amount of a residual solvent, cleaning agent, or active pharmaceutical ingredient that can remain in a product without causing harm. PDE assessments are required under ICH Q3C (residual solvents), ICH Q3D (elemental impurities), and EMA guidelines for cleaning validation in pharmaceutical manufacturing. RABT Global’s PDE toxicology assessment services provide scientifically justified, regulatory-submission-ready PDE reports.
A: Benefit-risk assessment services are required as part of marketing authorisation applications (summarising the clinical benefit-risk profile of a new drug or device), periodic safety update reports (PSUR/PBRER), post-approval safety referrals, and risk management plans. RABT Global’s benefit-risk analysis for submissions follows the CHMP benefit-risk methodology (MCDA framework) and provides a structured, health authority-ready benefit-risk assessment for all applicable regulatory contexts.
A: RABT Global combines specialist toxicology regulatory services expertise with a proven track record across 200+ global clients. Our regulatory team brings multi-jurisdictional knowledge, integrated regulatory and medical writing capabilities, and a genuine partnership approach — making us the toxicology regulatory services provider of choice for pharmaceutical and medical device companies worldwide.
Expert Toxicology & Safety Reports (PDE / Benefit-Risk) — Partner with RABT Global
Get specialist toxicology regulatory services from RABT Global’s expert regulatory team. Trusted by 200+ life sciences companies worldwide.